← Back to Search

Other

Cytosponge Test for Esophageal Cancer (REACT Trial)

N/A

Waitlist Available

Led By Julian Abrams, MD, MPH

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 day

Awards & highlights

REACT Trial Summary

This trial will test a new, non-invasive screening device for Barrett's Esophagus. 100 patients will be enrolled and monitored for 2 weeks to 2 months.

Eligible Conditions

Esophageal Cancer
Barrett's Esophagus

REACT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 day

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 day

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Participate Rate

Patient Tolerability determined by Score on Likert Scale

Secondary outcome measures

Number of Adverse Events (AEs)

Number of Serious Adverse Events (SAEs)

Positive Predictive Value (PPV)

REACT Trial Design

1Treatment groups

Experimental Treatment

Group I: Cytosponge TestExperimental Treatment1 Intervention

This arm will include individuals without formal diagnosis of Barrett's esophagus.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cytosponge

2014

N/A

~190

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor

1,431 Previous Clinical Trials

2,460,731 Total Patients Enrolled

Julian Abrams, MD, MPHPrincipal InvestigatorColumbia University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to be a part of this clinical experiment?

"To qualify for the trial, applicants must possess barrett esophagus and be between 50-75 years old. The maximum capacity of this medical study is estimated to encompass 100 patients."

Answered by AI

Does this clinical trial include adults aged 20 and older?

"The criteria for taking part in this trial mandates that participants be between 50 and 75 years of age."

Answered by AI

How many individuals are taking part in this experiment?

"Affirmative. According to clinicaltrials.gov, this trial is actively seeking participants and was first posted on August 1st 2018. Up until June 22nd 2022 it has been updated multiple times in order for 100 individuals from 2 sites to be enrolled."

Answered by AI

Are participants still enrolling in this experiment?

"According to clinicaltrials.gov, this trial is presently enrolling candidates. The initial post date was August 1st 2018 and the most recent update came on June 22nd 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Rapid Assessment of Esophageal Adenocarcinoma Risk Test

Julian A Abrams, MD 2018. "Rapid Assessment of Esophageal Adenocarcinoma Risk Test". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03366012.